Insider Transactions in Q3 2022 at Caladrius Biosciences, Inc. (CLBS)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2022
|
Mohammad Azab Director |
BUY
Grant, award, or other acquisition
|
Direct |
19,200
+50.0%
|
$115,200
$6.25 P/Share
|
|
Sep 01
2022
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
69,742
-8.62%
|
$0
$0.5 P/Share
|
|
Sep 01
2022
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+15.64%
|
$0
$0.5 P/Share
|
|
Sep 01
2022
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
69,959
-9.7%
|
$0
$0.5 P/Share
|
|
Sep 01
2022
|
Kristen K Buck EVP, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
58,000
+13.33%
|
$0
$0.5 P/Share
|